PetMed Express, Inc.
PETSHealthcareNASDAQPharmaceutical Retailers · Last scanned Oct 26, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, PetMed Express, Inc. focuses on Pharmaceutical Retailers services and products. PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The $26.4M market capitalization puts PETS squarely in micro-cap range for its industry. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.
Market Cap
$26.4M
Beta
0.84
P/E (TTM)
—
P/E (Fwd)
-40.67
EPS (TTM)
$-1.38
EPS (Fwd)
$-0.03
ROE
-78.6%
ROA
-20.1%
Cash
$13.1M
Total Debt
$414,000
Free CF
-$16.0M
52W Change
-54.1%
Annual Financials
Cash vs Debt
Where PETS stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, PETS finished 40.72% below its 150-day moving average ($1.94) and 47.96% below its 200-day moving average ($2.21). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is PETS overbought or oversold?
At the October 20, 2026 close, PETS's RSI(14) was 12.1, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
PetMed Express, Inc. holds $13.1M in cash against $414K in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company is burning cash, with free cash flow at -$16.0M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -78.6% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $303.6M (2021) to $179.0M (2026), a 41% decline worth watching.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. No single metric tells the full story. Reviewing PETS's risk profile alongside its fundamentals and technical indicators provides a more complete picture.